Vyant Bio (VYNT)
US Market

Vyant Bio (VYNT) Balance Sheet


Vyant Bio Balance Sheet

Vyant Bio's total assets for Q4 2022 were $14.06M, a decrease of -38.98% from the previous quarter. VYNT total liabilities were $5.30M for the fiscal quarter, a -42.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20
Total Assets
$ 14.06M$ 37.64M$ 4.05M
Total Liabilities
$ 5.30M$ 6.35M$ 40.49M
Total Equity Gross Minority
$ 9.91M$ 31.29M$ -36.44M
Total Capitalization
$ 11.60M$ 31.35M$ -29.60M
Preferred Stock Equity
--$ 29.01M
Capital Lease Obligations
--$ 1.11M
Currency in USD

Vyant Bio Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis